I’ve written much on this blog about the terrible consequences of the U.S. Supreme Court’s ruling in PLIVA v. Mensing. In that case, the Court found that victims of injuries…
Jeff LoweNovember 15, 2013
Because I practice pharmaceutical injury law nationwide, I’ve been very interested in the debate over “innovator liability” in Alabama. That’s the name for the legal theory the Alabama Supreme Court…
Jeff LoweSeptember 5, 2013
In the past few years, the U.S. Supreme Court has made life even tougher for victims of injuries caused by generic prescription drugs. In PLIVA v. Mensing, the Court barred…
Jeff LoweAugust 30, 2013
According to recent reports, the acid reflux drug Reglan is now facing new restrictions in Europe because of the drug’s link to neurological disorders like tardive dyskinesia. These new restrictions…
Jeff LoweAugust 12, 2013
Last month, I wrote here as a dangerous drug lawyer about an Eighth U.S. Circuit Court of Appeals decision involving claims against generic and name-brand Reglan makers. In Bell v.…
Jeff LoweJuly 19, 2013
Last week, I wrote as a pharmaceutical liability lawyer about a generic Reglan injury lawsuit at the U.S. Supreme Court, which closed another legal avenue of recovery against drug manufacturers.…
Jeff LoweJuly 3, 2013
As I’ve written here many times, the appeals courts have not yet settled whether and how injured people may pursue payment for injuries caused by defective generic prescription drugs. After…
Jeff LoweJune 20, 2013
As a pharmaceutical liability lawyer, I’ve written several posts here recently about generic Reglan lawsuits. Generic versions of Reglan, a drug for gastroesophageal reflux disease, have been the subjects of…
Jeff LoweMarch 20, 2013
Pfizer, the makers of the acid reflux drug Reglan, filed a rehearing request on February 19 that is asking the Alabama Supreme Court to reconsider one of its recent rulings…
Jeff LoweMarch 15, 2013